Evaxion Biotech AS (EVAX) stock has reached a new 52-week low, touching down at $3.06, with InvestingPro data showing the stock's RSI indicating oversold territory. The company faces a challenging ...

Studies have shown that physical and functional interactions of human endogenous retrovirus proteins Np9 and Rec with the promyelocytic leukemia zinc finger protein (PLZF). One major target of PLZF is ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...